Mónica Martín de Bustamante
CEO & Managing Director
Ms. Martin de Bustamante's career has focused on pharmaceutical global pricing and market access issues for biopharmaceutical and pharmaceutical products. Her time has been apportioned between the emerging and mature markets, with a strong focus on Latin America (Mexico, Argentina, Colombia, Brazil), Asia (China, India, Philippines, Thailand) and Southern Europe (Spain, Italy). Through thousands of in-depth interviews conducted in the countries' native languages Ms. Martin de Bustamante has fortified her understanding of how these markets are rapidly evolving cost-containment policy.
Much of Ms. Martin de Bustamante's work to date has centred around understanding the barriers to access and reimbursement challenges posed by developing economies in the emerging markets and the continuous reforms throughout Europe. She has extensive international experience in price integrity, global market access strategies, therapeutic area financing trends, payer-based biosimilar strategy, and patient assistance programs.
Ms. Martin de Bustamante holds a Bachelors in Biomedical Engineering and a Bachelors in Romance Languages & Engineering Sciences from Dartmouth College. She is fluent in Spanish and Italian.
Developing an early stage biopharmaceutical asset in Europe: Navigating treacherous waters
29 October 2019
PDx: Emerging Secrets to Success (and Failures)
9 October 2017
Poster at ISPOR international on the role of indirect comparisons in the AMNOG evaluation procedure
18 May 2015
Turning Tides: is 70% the new 30% biosimilar discount?
8 May 2015